A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/39 (2006.01) A61K 31/7088 (2006.01) A61K 39/21 (2006.01) A61P 31/18 (2006.01)
Patent
CA 2557443
The invention relates to the therapeutic use of a second generation immunomodulatory oligonucleotide in combination with HIV-1 antigen or immunogen to enhance the ability to reduce the risk HIV infection and to control the progression of HIV infection to prevent AIDS Related Complex (ARC) and AIDS.
L'invention concerne l'utilisation thérapeutique d'un oligonucléotide immunomodulateur de seconde génération, en combinaison avec un antigène ou un immunogène VIH-1 pour renforcer la capacité à réduire le risque d'infection par VIH et pour réguler la progression de l'infection à VIH, de manière à prévenir le syndrome apparenté au SIDA, ainsi que le SIDA.
Agrawal Sudhir
Bartholomew Richard
Bray Dorothy
Clerici Mario
Kandimalla Ekambar
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hybridon Inc.
The Immune Response Corporation
LandOfFree
Enhanced activity of hiv vaccine using a second generation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced activity of hiv vaccine using a second generation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced activity of hiv vaccine using a second generation... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1371152